Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care.

Related Articles Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care. Cochrane Database Syst Rev. 2018 06 05;6:CD006332 Authors: Candy B, Jones L, Vickerstaff V, Larkin PJ, Stone P Abstract BACKGROUND: Opioid-induced bowel dysfunction (OIBD) is characterised by constipation, incomplete evacuation, bloating, and gastric reflux. It is one of the major adverse events of treatment for pain in cancer and in palliative care, resulting in increased morbidity and reduced quality of life.This is an update of two Cochrane reviews. One was published in 2011, Issue 1 on laxatives and methylnaltrexone for the management of…
Origen: Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care. – PubMed